Business Standard

Serum Institute applies for EU nod through drugmaker AstraZeneca

SII Chief Executive Officer Adar Poonawalla said on Mon­day he had taken it up at the "highest levels".

Adar Poonawalla, CEO, Serum Institute
Premium

Adar Poonawalla, CEO, Serum Institute of India

Sohini Das Mumbai
Amid concern around visits to Europe by individuals who to­ok the jab of Serum Institute of India (SII), company sources have said SII has applied for marketing auth­ori­sation before the European Medicine Age­ncy (EMA) thro­ugh British drug­maker Astra­Zeneca, its vaccine partner.

So far, 287 million Covis­hield shots, single and double, have been given in India, and the company has exported close to 70 million doses.

SII Chief Executive Officer Adar Poonawalla said on Mon­day he had taken it up at the “highest levels”. If Euro­pean Union (EU) restriction on Covishield continues, at least a few hundred million people would face challenges entering

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jun 29 2021 | 11:03 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com